Dr. Reddy’s Laboratories informs about information on newspaper publication

05 Sep 2023 Evaluate

In reference to Regulation 30(11) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) regarding a news item published in The Economic Times (newspaper/ media) on September 5, 2023, with the heading ‘Bain Dials Dr Reddy’s Laboratories to team up for joint Cipla Bid’. The said news item is about 'Private equity firm Bain Capital has approached Indian pharmaceutical company Dr Reddy's Laboratories (DRL) to explore a joint bid for the promoters of Cipla’. In this regard, Dr. Reddy’s Laboratories has informed that the Company does not comment on market speculations and there is currently no such event or information which requires a disclosure under Regulation 30 of the SEBI Listing Regulations. In compliance with Regulation 30 of the SEBI Listing Regulations, the Company makes prompt disclosure of any event or information, as and when any event or information is considered material or warrants such disclosure under the said Regulation.

The above information is a part of company’s filings submitted to BSE.


Dr. Reddys Lab Share Price

1265.95 -2.65 (-0.21%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×